Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq 16:00:00 2024-06-28 EDT After market 17:27:33
12.1 USD -0.78% Intraday chart for Walgreens Boots Alliance, Inc. 12.09 -0.04%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Walgreens' Q3 Earnings Miss Reflects Weak Consumer Spending, Pharmacy Headwinds, Morgan Stanley Says MT
Walgreens' Earnings Guidance Cut Implies 'Notably Weaker' Fourth Quarter, Morgan Stanley Says MT
Walgreens Boots Alliance's Fiscal Q3 Results Reflect Pharmacy Headwinds, Challenging Retail Environment, Truist Securities Says MT
BofA Securities Slashes Price Target on Walgreens Boots Alliance to $11 From $22, Maintains Underperform Rating MT
Truist Cuts Price Target on Walgreens Boots Alliance to $13 From $20, Calls Fiscal Q3 'Difficult,' Keeps Hold Rating MT
Mizuho Adjusts Price Target on Walgreens Boots Alliance to $15 From $19, Maintains Neutral Rating MT
Morgan Stanley Lowers Price Target on Walgreens Boots Alliance to $9 From $13 Amid Guidance Cut, Keeps Underweight Rating MT
Barclays Adjusts Price Target on Walgreens Boots Alliance to $11 From $15, Maintains Underweight Rating MT
Deutsche Bank Adjusts Price Target on Walgreens Boots Alliance to $13 From $22, Maintains Hold Rating MT
Wall St. subdued ahead of debate, inflation data RE
Equities Rise as Markets Analyze Fed Official's Remarks, Macro Data MT
Equities Rise Amid Fed Official's Rate Remarks, Macro Data MT
US Equities Markets Close Higher Thursday as Investors Review Economic Data, Fed Official's Remarks MT
Sector Update: Health Care Stocks Slipping Late Afternoon MT
Wall Street closes subdued as investors sit, wait for inflation data RE
Leerink Partners Cuts Walgreens Boots Alliance's Price Target to $11 From $17 MT
Equity Markets Rise Intraday After Macro Data, Fed Official's Comments MT
Sector Update: Health Care Stocks Decline in Afternoon Trading MT
Sector Update: Health Care MT
Nephron Research Cuts Walgreens Boots Alliance's Price Target to $13 From $24, Hold Rating Maintained MT
US Equity Indexes Choppy, Treasury Yields Decline in Midday Trading MT
Walgreens cuts profit view, looks to shut more stores RE
Evercore ISI Adjusts Price Target on Walgreens Boots Alliance to $10 From $17 MT
Wall St listless as eyes on crucial inflation data; Micron, Walgreens slump RE
Top Midday Stories: Walgreens Shares Tumble on Lower Guidance, Store Closures; SM Energy, NOG to Buy XCL Resources; Uber, Lyft Worker Classification Heads to Massachusetts Ballot MT
Chart Walgreens Boots Alliance, Inc.
More charts
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
12.19 USD
Average target price
17.4 USD
Spread / Average Target
+42.70%
Consensus
  1. Stock Market
  2. Equities
  3. WBA Stock
  4. News Walgreens Boots Alliance, Inc.
  5. UBS Cuts Price Target on Walgreens Boots Alliance to $17 From $22, Maintains Neutral Rating